POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy.

ABSTRACT:

SUBMITTER: Chen YX 

PROVIDER: S-EPMC8473642 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature